Shares jump after the company reports strong quarterly results and management shares some news about Medicare.
The innovative oncology company posted 41% revenue growth and achieved positive operating income for the first time in its history.
Everything is going well for the life sciences service provider.
Shares slumped after the company reported results that missed the mark.
Sales and profits took a step backward in the second quarter as the company continues to deal with customer issues.
Find out which stocks have our team of healthcare experts feeling excited right now.
Shares jump after the biopharma receives some praise from Wall Street.
Shares slump after the drugmaker releases bummer clinical news.
Autodesk is the $30 billion SaaS company that hardly anyone has heard of, and it’s set up for serious growth.
Shares drop on a slow news day. What can explain the move?
The roller coaster ride continues.
Here's why this team of biotech experts are giddy about these stocks right now.
Traders cheer after the company reports a regulatory win.
Shares jump after the company receives some love from the analyst community.
It can be tough to pick winners in the world of pharmaceutical development, but Alexion, Regeneron, and Ionis offer investors good chances of strong returns.
Find out why Cardinal Health, CannTrust Holdings, and Abiomed have our healthcare experts feeling giddy right now.
These three businesses are a great way for investors to support the war on cancer.
Shares shoot higher after the company reports upbeat earnings.
You probably haven't heard of any of these businesses, but they're worth a look.
Here's why ViewRay, Nevro, and LaMaitre Vascular could all be great healthcare stocks to own.